We are live on ! Find out more
MIP

Marietta Investment Partners Portfolio holdings

AUM $582M
1-Year Est. Return 54.15%
This Fund
S&P 500
This Quarter Est. Return
+2.08%
1 Year Est. Return
+54.15%
3 Year Est. Return
+159.91%
5 Year Est. Return
+239.2%
10 Year Est. Return
+1,894.68%
AUM
$436M
AUM Growth
-$2.52M
Cap. Flow
-$3.99M
Cap. Flow %
-0.91%
Top 10 Hldgs %
32.62%
Holding
189
New
9
Increased
41
Reduced
57
Closed
10

Top Sells

Rank Stock Value
1
AMED
Amedisys
AMED
+$7.06M
2
LUV icon
Southwest Airlines
LUV
+$6.15M
3
RIO icon
Rio Tinto
RIO
+$5.62M
4
GNRC icon
Generac Holdings
GNRC
+$3.96M
5
TSM icon
TSMC
TSM
+$3.01M

Sector Composition

Rank Sector Weight
1 Technology 22.83%
2 Financials 17.75%
3 Industrials 16.57%
4 Healthcare 15.03%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.45T
$26.3M 6.03%
185,764
-240
-0.1% -$35.3K
GNRC icon
2
Generac Holdings
GNRC
$13B
$18.9M 4.34%
46,349
-9,236
-17% -$3.96M
MSFT icon
3
Microsoft
MSFT
$3.71T
$17.2M 3.94%
60,905
-3,000
-5% -$873K
HDB icon
4
HDFC Bank
HDB
$120B
$14.6M 3.35%
399,680
-6,228
-2% -$231K
TMO icon
5
Thermo Fisher Scientific
TMO
$219B
$13.8M 3.15%
24,069
-13
-0.1% -$7.13K
FCX icon
6
Freeport-McMoran
FCX
$94B
$12.2M 2.79%
374,047
-19,220
-5% -$677K
MSCI icon
7
MSCI
MSCI
$41.4B
$11.6M 2.67%
19,127
-283
-1% -$173K
PYPL icon
8
PayPal
PYPL
$51.3B
$9.53M 2.18%
36,625
-4
-0% -$1.14K
EW icon
9
Edwards Lifesciences
EW
$53.1B
$9.44M 2.16%
83,354
-976
-1% -$111K
ASML icon
10
ASML
ASML
$704B
$8.77M 2.01%
11,768
+3,902
+50% +$3.07M
GOOGL icon
11
Alphabet (Google) Class A
GOOGL
$4.24T
$8.29M 1.9%
62,040
+40,380
+186% +$5.49M
FRC
12
DELISTED
First Republic Bank
FRC
$7.95M 1.82%
41,233
+120
+0.3% +$23.6K
POOL icon
13
Pool Corp
POOL
$7.21B
$7.86M 1.8%
18,083
+593
+3% +$281K
ULTA icon
14
Ulta Beauty
ULTA
$22B
$7.84M 1.8%
21,719
+1,995
+10% +$721K
MA icon
15
Mastercard
MA
$495B
$7.81M 1.79%
22,459
-475
-2% -$173K
NVDA icon
16
NVIDIA
NVDA
$5.45T
$7.62M 1.75%
367,750
+351,670
+2,187% +$7.3M
IDXX icon
17
Idexx Laboratories
IDXX
$44.1B
$7.55M 1.73%
12,146
-1,571
-11% -$1.06M
WST icon
18
West Pharmaceutical
WST
$24.4B
$6.26M 1.43%
+14,739
New +$6.21M
URI icon
19
United Rentals
URI
$71.8B
$6.16M 1.41%
17,538
+84
+0.5% +$28.2K
TX icon
20
Ternium
TX
$10.7B
$6.14M 1.41%
145,196
+3,220
+2% +$157K
NVO
21
Novo Nordisk
NVO
$203B
$6.07M 1.39%
126,534
+540
+0.4% +$26.1K
BRK.B icon
22
Berkshire Hathaway Class B
BRK.B
$1.08T
$6M 1.38%
21,988
LULU icon
23
lululemon athletica
LULU
$13.5B
$5.87M 1.35%
14,502
+2,136
+17% +$856K
TSM icon
24
TSMC
TSM
$2.21T
$5.4M 1.24%
48,369
-25,630
-35% -$3.01M
DHR icon
25
Danaher
DHR
$143B
$4.76M 1.09%
17,643
+16,695
+1,761% +$4.54M

Similar funds

Marietta Investment Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Marietta Investment Partners held 189 positions worth $436M, down 0.58% from $439M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Marietta Investment Partners's Q3 2021 filing shows 9 new, 41 increased, 57 reduced and 10 closed positions. Its largest new stake was West Pharmaceutical: 14,739 shares worth $6.26M. The largest sale was Amedisys, an estimated $7.06M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.

  • Marietta Investment Partners's largest Q3 2021 buy was West Pharmaceutical: 14,739 shares worth $6.26M.
  • Marietta Investment Partners added most to NVIDIA in Q3 2021, an estimated $7.3M increase.
  • Marietta Investment Partners's biggest Q3 2021 reduction was Southwest Airlines, cutting an estimated $6.15M.
  • Marietta Investment Partners fully exited Amedisys in Q3 2021, selling an estimated $7.06M.
  • Marietta Investment Partners's ten largest holdings make up 33% of its $436M portfolio in Q3 2021.
  • Marietta Investment Partners opened 9 new positions and closed 10 in Q3 2021.
  • Marietta Investment Partners's portfolio value fell 0.58% quarter-over-quarter to $436M.

Based on Marietta Investment Partners's 13F filing for Q3 2021, filed 9 Nov 2021.